跳至主要内容
临床试验/ISRCTN90155919
ISRCTN90155919进行中(未招募)未知

Working collaboratively with vulnerable women to identify the best implementation gains by screening cervical cancer more effectively in European countries

Clinical Investigation Center INSERM 14320 个研究点目标入组 2,100 人开始时间: 2022年6月21日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
2,100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • 1. Included in the vulnerable group of women as defined by other working groups of the project (which may include women of low socioeconomic status, women living with HIV or other sexually transmitted diseases, sex workers, Roma population and migrants)
  • 2. Age within that specified in the guideline for CCS in the country/programme (Estonia: 30-65 yrs; Portugal: 25-64 yrs; Romania: 30-64 yrs)
  • 3. Provides voluntary informed consent

排除标准

  • 1. Screened with cytology in last 3 years or with HPV test in last 5 years
  • 2. Those who had hysterectomy
  • 3. Those who have been detected cervical precancer or cancer and undergoing treatment for that
  • 4. Those suffering a debilitating illness that will prevent her from providing informed consent

研究者

发起方
Clinical Investigation Center INSERM 1432

相似试验